Samsung Bioepis Sees Success With Soliris Biosimilar

SB12 Eculizumab Candidate Demonstrates Equivalence In Phase III Trial

 
• By Dave Wallace
Pen tick check list boxes
SB12 showed equivalence in efficacy, safety, PK, PD and immunogenicity • Source: Shutterstock

More from Biosimilars

More from Products